Surgically Treating Hidradenitis Suppurativa that does not Respond to Medical Treatment

musa kemal keleş, Uğur Horoz, ergin seven, ali teoman tellioğlu

Özet


Objective: Hidradenitis suppurativa is a chronic inflammatory disease of the skin involving the infundibular terminal follicles in the areas of
the body containing apocrine glands. The pathology leads to purulent drainage and pain, abscesses, hypertrophic scars, and sinus formation
in the affected areas. Treatment options for the disease include retinoid, antibiotics, antiandrogens, immunosuppressive agents, laser
therapy/phototherapy, and surgery. This study aimed to assess the results of surgical treatment in patients who could not be treated medically.
Materials and Methods: This study reviewed twenty patients who did not heal with medical treatment in the last 5 years. Results: Defect
reconstructions were performed using grafts on eight patients, flaps on five patients, and primary closure on seven patients. One patient had a
long‑term recurrence. Conclusion: In the researchers’ experience with different reconstruction methods and the wide excision of the disease,
clinically satisfactory results can be achieved in cases that do not heal with medical treatment.

Tam Metin:

PDF

Referanslar


Chinniah N, Cains GD. Moderate to severe hidradenitis suppurativa treated with biological therapies. Australasian Journal of Dermatology. 2014;55(2):128-31.

Collier F, Smith RC, Morton CA. Diagnosis and management of hidradenitis suppurativa. BMJ. 2013;346:f2121.

Falola RA, DeFazio MV, Anghel EL, Mitnick CDB, Attinger CE, Evans KK. What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plastic and reconstructive surgery. 2016;138(3S):219S-29S.

Humphries LS, Kueberuwa E, Beederman M, Gottlieb LJ. Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: A single-center experience. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2016;69(4):554-66.

Ingram J. Hidradenitis suppurativa outcome measures and treatment goals. British Journal of Dermatology. 2014;171(6):1293-4.

Jemec G. Biomarkers in hidradenitis suppurativa. British Journal of Dermatology. 2013;168(6):1151-3.

John H, Manoloudakis N, Sinclair JS. A systematic review of the use of lasers for the treatment of hidradenitis suppurativa. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2016;69(10):1374-81.

Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Reviews in Endocrine and Metabolic Disorders. 2016:1-7.

Kohorst JJ, Baum CL, Otley CC, Roenigk RK, Schenck LA, Pemberton JH, et al. Surgical Management of Hidradenitis Suppurativa: Outcomes of 590 Consecutive Patients. Dermatologic Surgery. 2016;42(9):1030-40.

Menderes A, Sunay O, Vayvada H, Yilmaz M. Surgical management of hidradenitis suppurativa. Int J Med Sci. 2010;7(4):240-7.

Miller IM, Dufour DN, Jemec GB. Treatment of hidradenitis suppurativa: Is oral isoniazid an option? Journal of Dermatological Treatment. 2012;23(2):128-30.




Online ISSN:2528-8644
Basılı ISSN:1300-6878 (önceki)

Türk Plastik Rekonstrüktif ve Estetik Cerrahi Dergisi (Turk J Plast Surg),
Türk Plastik Rekonstrüktif ve Estetik Cerrahi Derneği'nin, Estetik Plastik Cerrahi Derneği'nin, Türkiye Interplast Derneği'nin ve Çene Yüz Cerrahları Derneği'nin yayın organıdır.